Lopinavir/Ritonavir
Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.
What Lopinavir/Ritonavir Means in Everyday Medical Language
Lopinavir/ritonavir is a medicine made by combining two drugs called lopinavir and ritonavir. It is mainly used to treat and prevent HIV infection, the virus that causes AIDS. Lopinavir works by blocking HIV’s ability to make copies of itself, which helps control the infection. Ritonavir is included in a low dose to slow down the breakdown of lopinavir in the body, allowing it to stay active longer. This combination helps keep the virus under control. The medicine is sold under brand names like Kaletra and is taken by mouth as tablets, capsules, or liquid.
Why Lopinavir/Ritonavir Can Matter in Cancer Care
Although lopinavir/ritonavir is primarily an HIV medicine, researchers have studied it for possible roles in cancer treatment. Some early research suggests it might help other anticancer drugs work better or might block the growth of certain cancer cells. However, this use is still experimental and not part of standard cancer care. If you see lopinavir/ritonavir mentioned in a cancer care context, it’s important to ask your care team what it means for your specific situation.
What Patients Might See or Be Told About Lopinavir/Ritonavir
You might encounter the terms lopinavir/ritonavir or Kaletra in your medical records, treatment plans, or discussions with your healthcare team. These names refer to the same combination medicine used mainly for HIV. Common side effects include diarrhea, nausea, tiredness, headaches, and muscle pain. Serious side effects are less common but can include liver problems or pancreatitis. In 2011, the U.S. Food and Drug Administration (FDA) warned that the liquid form of lopinavir/ritonavir should be avoided in premature babies due to serious health risks related to an ingredient called propylene glycol.
Where Lopinavir/Ritonavir Might Appear in Medical Information
You may see lopinavir/ritonavir or Kaletra mentioned in medical records, treatment plans, clinical trial descriptions, or drug information sheets. It is primarily part of HIV treatment or prevention plans but may also appear in research related to cancer. Because the medicine has several names, comparing the exact wording in your records can help avoid confusion.
What Lopinavir/Ritonavir Does Not Automatically Mean
Seeing lopinavir/ritonavir or Kaletra mentioned does not automatically mean you have HIV or cancer, nor does it mean it is the main treatment for cancer. It is primarily an HIV medicine and is not a standard cancer therapy. The presence of this term in your records should be discussed with your care team to understand its specific role in your care.
How to Read Lopinavir/Ritonavir in Context
If you see lopinavir/ritonavir mentioned in a report, test result, or treatment plan, the safest step is to ask your care team what it means for your specific situation. Don’t treat the word alone as a diagnosis or treatment recommendation. Your healthcare providers can explain why it is part of your care and what to expect.
Safety and Next Steps
This information is educational and does not decide what is safe or appropriate for any individual patient. If lopinavir/ritonavir appears in your medical records or treatment plan, the best next step is to ask your healthcare team to explain what it means for you personally. They can help you understand its role, possible side effects, and how it fits into your overall care.
Sources
Public source information used for this glossary entry includes: